title: Response to "concerns about the statistical methodology described in the 'clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors'".
authors: BGI-Shenzhen, Shenzhen, China.
authors: Wei
authors: W
authors: Wang
mesh_terms: D002887:Chromosomes, Human, Pair 18; D004314:Down Syndrome / Q000175:diagnosis*; D005260:Female; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D062145:Maternal Serum Screening Tests; D011247:Pregnancy; D014314:Trisomy / Q000175:diagnosis*